151751-Najiba-Chargi

107 Surgery: skeletal muscle mass and free fibula flap reconstruction 15. Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. Eur J Cancer . 2016;57:58- 67. doi:10.1016/j.ejca.2015.12.030 16. van Vugt JLA, Buettner S, Levolger S, et al. Low skeletal muscle mass is associat - ed with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract. Bianchi C, ed. PLoS One . 2017;12(10):e0186547. doi:10.1371/journal. pone.0186547 17. Wendrich AW, Swartz JE, Bril SI, et al. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer. 2017. doi:10.1016/j.oraloncol - ogy.2017.05.012 18. Choi MH, Oh SN, Lee IK, Oh ST, Won DD. Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer. J Cachexia SarcopeniaMuscle . 2018;9(1):53-59. doi:10.1002/jcsm.12234 19. Choi MH, Yoon SB, Lee K, et al. Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer. J Cachexia Sarcopenia Muscle . 2018;9(2):326-334. doi:10.1002/jcsm.12274 20. Suh JW, Paik HC, Yu WS, et al. Effect of Sar - copenic Overweight on Lung Transplant Based in Three-Dimensional Reconstruct- ed Psoas Muscle Mass. Ann Thorac Surg . 2019;107(6):1626-1631. doi:10.1016/j.atho - racsur.2019.01.007 21. Swartz JE, Pothen AJ, Wegner I, et al. Feasibility of using head and neck CT im - aging to assess skeletal muscle mass in head and neck cancer patients. Oral Oncol . 2016;62:28-33. doi:10.1016/j.oraloncolo - gy.2016.09.006 22. Dindo D, Demartines N, Clavien PA. Clas - sification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg . 2004;240(2):205-213. doi:10.1097/01. sla.0000133083.54934.ae 23. Wendrich AW, Swartz JE, Bril SI, et al. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer. Oral Oncol . 2017;71:26-33. doi:10.1016/j.oraloncology.2017.05.012 24. Zhang X, Wang C, Dou Q, Zhang W, Yang Y, Xie X. Sarcopenia as a predictor of all-cause mortality among older nursing home resi- dents: A systematic review and meta-anal- ysis. BMJ Open . 2018;8(11). doi:10.1136/ bmjopen-2017-021252 25. Chargi N, Bril SI, Emmelot-Vonk MH, de Bree R. Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer. Eur Arch Oto-Rhi- no-Laryngology . 2019;276(5):1475-1486. doi:10.1007/s00405-019-05361-4 26. Tang T, Wu L, Yang L, et al. A sarcopenia screening test predicts mortality in hos- pitalized older adults. Sci Rep . 2018;8(1). doi:10.1038/s41598-018-21237-9 27. Deng HY, Zha P, Zhou Q. Sarcopenia: An unneglectable nutritional status for pa- tients with surgically treated non-small- cell lung cancer. Eur J Cardio-thoracic Surg . 2019;56(2):420. doi:10.1093/ejcts/ezy435 28. Kudou K, Saeki H, Nakashima Y, et al. Prognostic Significance of Sarcopenia in Patients with Esophagogastric Junction Cancer or Upper Gastric Cancer. Ann Surg Oncol . 2017;24(7):1804-1810. doi:10.1245/ s10434-017-5811-9 29. AchimV, Bash J, Mowery A, et al. Prognostic Indication of Sarcopenia for Wound Com - plication After Total Laryngectomy. JAMA Otolaryngol Neck Surg . 2017;143(12):1159. doi:10.1001/jamaoto.2017.0547 6